RecruitingNCT05913947
Lithium versus cariprazine for depression in bipolarity
About this title
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
Read the official source — NCT05913947Medication studyAges 18–65Denmark
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
What will I do during this study?
You are randomly assigned to lithium or cariprazine as the study treatment. The treating physician can adjust the dose according to the study protocol.
- Listed locations
- AalborgSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 13, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 122
- Sponsor
- Aalborg University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Denmark
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05913947
- Official title
Show the full official title
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression: a Pragmatic Head-to-head Open, Randomized Multicenter Study: The 9th Study of the Danish University Antidepressant Group (DUAG 9)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Aalborg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Aalborg University Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including lithium and Cariprazine.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Flumazenil during ECT and thinking or memory in depression or bipolarity
Lithium versus cariprazine in the acute phase treatment of Depression in bipolarity: a pragmatic head-to-head open, randomized multicenter study. The 9th study of the Danish University Antidepressant Gro...
